It is has been observed in several cell systems that cisplatin can radiosensitize and that the response of cells to combination cisplatin and radiation depends on several factors. These include the radiation dose and drug concentration used, the order in which the two treatments are administered, and the time between their administration. The response of a head and neck squamous carcinoma cell line to combination cisplatin-radiation treatment was examined. The response was found to be additive when cisplatin was given first, regardless of the timing and magnitude of the treatments administered. When cells were treated with radiation first, antagonism was observed for low radiation doses and drug concentrations. The response may be explained by a low radiation dose induction of processes that protect the cell from a second damaging agent, similar to the adaptive response. There is some indication in the literature that cisplatin can preferentially radiosensitize cells that are proficient in certain types of DNA repair. Therefore, the response of a cisplatin-resistant strain of the SCC-25 cell line was also investigated. The cisplatin-resistant cell line was found to be substantially radiosensitized by cisplatin for moderate amounts of radiation and cisplatin. The results are discussed with reference to the current proposed mechanisms for cisplatin-radiation interaction. / Thesis / Master of Science (MS)
| Identifer | oai:union.ndltd.org:mcmaster.ca/oai:macsphere.mcmaster.ca:11375/24209 |
| Date | January 1996 |
| Creators | Caney, Colleen |
| Contributors | Singh, Gurmit, Physics |
| Source Sets | McMaster University |
| Language | English |
| Detected Language | English |
| Type | Thesis |
Page generated in 0.0024 seconds